Is Cirrhotic Cardiomyopathy Related to Cirrhosis Severity?

Subhash Chandra Dash1, Beeravelli Rajesh2, Suresh Kumar Behera3

  • 1Department of General Medicine, Institute of Medical Sciences & SUM Hospital, Bhubaneswar, India.

Insights

Cirrhotic cardiomyopathy (CCM) is more common in severe liver cirrhosis. This study found that cardiac dysfunction, particularly systolic dysfunction, worsens with cirrhosis severity, impacting patient outcomes.

Area of Science:

  • Cardiology
  • Hepatology
  • Internal Medicine

Background:

  • Cirrhotic cardiomyopathy (CCM) is a significant complication of liver cirrhosis, contributing to increased patient morbidity and mortality.
  • The relationship between CCM and the severity of liver cirrhosis remains incompletely understood, with contradictory findings in existing literature.
  • Early diagnosis and understanding of CCM are crucial for managing patients with liver cirrhosis.

Purpose of the Study:

  • To investigate the prevalence of cardiac dysfunction in an Indian population with liver cirrhosis.
  • To explore the correlation between cirrhotic cardiomyopathy and the severity of liver cirrhosis, assessed using MELD and CTP scores.
  • To identify specific patterns of cardiac dysfunction, including systolic and diastolic abnormalities, in patients with cirrhosis.

Main Methods:

  • Ninety-six patients diagnosed with liver cirrhosis but without pre-existing cardiac conditions were enrolled.
  • Participants underwent clinical evaluation, electrocardiography, and echocardiography to assess cardiac function.
  • Cirrhosis severity was quantified using the Model for End-stage Liver Disease (MELD) and Child-Turcotte-Pugh (CTP) scoring systems.

Main Results:

  • Cirrhotic cardiomyopathy was diagnosed in 39.6% of patients.
  • Patients with CCM exhibited significantly higher CTP (9.6±2.6 vs. 8.3±2.3) and MELD (19.72±4.9 vs. 17.41±4.1) scores compared to those without CCM.
  • Systolic dysfunction and reduced left ventricular ejection fraction were more prevalent in advanced stages of cirrhosis (CTP-C).

Conclusions:

  • Cirrhotic cardiomyopathy demonstrates a positive correlation with the severity of liver cirrhosis.
  • Progressive decline in systolic cardiac function is observed as cirrhosis severity increases.
  • Overt systolic dysfunction is particularly common in advanced stages of liver cirrhosis, underscoring the need for cardiac monitoring.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
16
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
15
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
22
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
33
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
25
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
27